|
Volumn 419, Issue 1-2, 2011, Pages 235-239
|
European Paediatric Formulation Initiative's (EuPFI) 2nd conference commentary-Formulating better medicines for children
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EXCIPIENT;
PARACETAMOL;
DRUG;
ARTICLE;
CHILDHOOD MORTALITY;
COST EFFECTIVENESS ANALYSIS;
DIARRHEA;
DRUG BIOAVAILABILITY;
DRUG FORMULATION;
DRUG QUALITY;
DRUG SAFETY;
EUROPE;
GERMANY;
GOOD MANUFACTURING PRACTICE;
HEALTH HAZARD;
HUMAN;
MALARIA;
MEDICAL LITERATURE;
OCCUPATIONAL HAZARD;
OFF LABEL DRUG USE;
PALATABILITY;
PERSONALIZED MEDICINE;
PHARMACIST;
PNEUMONIA;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
TASTE;
CHILD;
CONFERENCE PAPER;
DRUG CONTROL;
DRUG DESIGN;
DRUG DOSAGE FORM;
DRUG INDUSTRY;
EUROPEAN UNION;
LEGAL ASPECT;
METHODOLOGY;
CHILD;
DOSAGE FORMS;
DRUG AND NARCOTIC CONTROL;
DRUG DESIGN;
DRUG INDUSTRY;
EUROPEAN UNION;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
|
EID: 84856416453
PISSN: 03785173
EISSN: 18733476
Source Type: Journal
DOI: 10.1016/j.ijpharm.2011.06.040 Document Type: Short Survey |
Times cited : (25)
|
References (10)
|